Antihypertensive

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

Despite significant decreases in sitting blood pressure (21-28 mmHg systolic reduction), antihypertensive therapy was not associated with increased orthostatic blood pressure declines or worsening of

Effect: null; No increases in orthostatic BP declines in any group; no worsening of orthostatic BFV declines

The relationship between on-treatment systolic blood pressure and primary outcome in very old hypertensive CAD patients follows a J-shaped curve, with the hazard ratio nadir at 140 mm Hg -- higher tha

Effect: mixed; HR nadir at SBP 140 mm Hg for very old (vs 110 mm Hg for aged <60 and 60-<70, and 135 mm Hg for aged 70-<80)

The relationship between on-treatment systolic blood pressure and primary outcome in very old hypertensive CAD patients follows a J-shaped curve, with the hazard ratio nadir at 140 mm Hg -- higher tha

Effect: mixed; HR nadir at SBP 140 mm Hg for very old (vs 110 mm Hg for aged <60 and 60-<70, and 135 mm Hg for aged 70-<80)

The relationship between on-treatment systolic blood pressure and primary outcome in very old hypertensive CAD patients follows a J-shaped curve, with the hazard ratio nadir at 140 mm Hg -- higher tha

Effect: mixed; HR nadir at SBP 140 mm Hg for very old (vs 110 mm Hg for aged <60 and 60-<70, and 135 mm Hg for aged 70-<80)

The relationship between on-treatment systolic blood pressure and primary outcome in very old hypertensive CAD patients follows a J-shaped curve, with the hazard ratio nadir at 140 mm Hg -- higher tha

Effect: mixed; HR nadir at SBP 140 mm Hg for very old (vs 110 mm Hg for aged <60 and 60-<70, and 135 mm Hg for aged 70-<80)

The relationship between on-treatment systolic blood pressure and primary outcome in very old hypertensive CAD patients follows a J-shaped curve, with the hazard ratio nadir at 140 mm Hg -- higher tha

Effect: mixed; HR nadir at SBP 140 mm Hg for very old (vs 110 mm Hg for aged <60 and 60-<70, and 135 mm Hg for aged 70-<80)

The relationship between on-treatment systolic blood pressure and primary outcome in very old hypertensive CAD patients follows a J-shaped curve, with the hazard ratio nadir at 140 mm Hg -- higher tha

Effect: mixed; HR nadir at SBP 140 mm Hg for very old (vs 110 mm Hg for aged <60 and 60-<70, and 135 mm Hg for aged 70-<80)

The relationship between on-treatment systolic blood pressure and primary outcome in very old hypertensive CAD patients follows a J-shaped curve, with the hazard ratio nadir at 140 mm Hg -- higher tha

Effect: mixed; HR nadir at SBP 140 mm Hg for very old (vs 110 mm Hg for aged <60 and 60-<70, and 135 mm Hg for aged 70-<80)

The relationship between on-treatment systolic blood pressure and primary outcome in very old hypertensive CAD patients follows a J-shaped curve, with the hazard ratio nadir at 140 mm Hg -- higher tha

Effect: mixed; HR nadir at SBP 140 mm Hg for very old (vs 110 mm Hg for aged <60 and 60-<70, and 135 mm Hg for aged 70-<80)

The relationship between on-treatment systolic blood pressure and primary outcome in very old hypertensive CAD patients follows a J-shaped curve, with the hazard ratio nadir at 140 mm Hg -- higher tha

Effect: mixed; HR nadir at SBP 140 mm Hg for very old (vs 110 mm Hg for aged <60 and 60-<70, and 135 mm Hg for aged 70-<80)

The relationship between on-treatment systolic blood pressure and primary outcome in very old hypertensive CAD patients follows a J-shaped curve, with the hazard ratio nadir at 140 mm Hg -- higher tha

Effect: mixed; HR nadir at SBP 140 mm Hg for very old (vs 110 mm Hg for aged <60 and 60-<70, and 135 mm Hg for aged 70-<80)

The relationship between on-treatment systolic blood pressure and primary outcome in very old hypertensive CAD patients follows a J-shaped curve, with the hazard ratio nadir at 140 mm Hg -- higher tha

Effect: mixed; HR nadir at SBP 140 mm Hg for very old (vs 110 mm Hg for aged <60 and 60-<70, and 135 mm Hg for aged 70-<80)

The relationship between on-treatment systolic blood pressure and primary outcome in very old hypertensive CAD patients follows a J-shaped curve, with the hazard ratio nadir at 140 mm Hg -- higher tha

Effect: mixed; HR nadir at SBP 140 mm Hg for very old (vs 110 mm Hg for aged <60 and 60-<70, and 135 mm Hg for aged 70-<80)

The relationship between on-treatment systolic blood pressure and primary outcome in very old hypertensive CAD patients follows a J-shaped curve, with the hazard ratio nadir at 140 mm Hg -- higher tha

Effect: mixed; HR nadir at SBP 140 mm Hg for very old (vs 110 mm Hg for aged <60 and 60-<70, and 135 mm Hg for aged 70-<80)

The relationship between on-treatment systolic blood pressure and primary outcome in very old hypertensive CAD patients follows a J-shaped curve, with the hazard ratio nadir at 140 mm Hg -- higher tha

Effect: mixed; HR nadir at SBP 140 mm Hg for very old (vs 110 mm Hg for aged <60 and 60-<70, and 135 mm Hg for aged 70-<80)

The relationship between on-treatment systolic blood pressure and primary outcome in very old hypertensive CAD patients follows a J-shaped curve, with the hazard ratio nadir at 140 mm Hg -- higher tha

Effect: mixed; HR nadir at SBP 140 mm Hg for very old (vs 110 mm Hg for aged <60 and 60-<70, and 135 mm Hg for aged 70-<80)

The relationship between on-treatment systolic blood pressure and primary outcome in very old hypertensive CAD patients follows a J-shaped curve, with the hazard ratio nadir at 140 mm Hg -- higher tha

Effect: mixed; HR nadir at SBP 140 mm Hg for very old (vs 110 mm Hg for aged <60 and 60-<70, and 135 mm Hg for aged 70-<80)

The relationship between on-treatment systolic blood pressure and primary outcome in very old hypertensive CAD patients follows a J-shaped curve, with the hazard ratio nadir at 140 mm Hg -- higher tha

Effect: mixed; HR nadir at SBP 140 mm Hg for very old (vs 110 mm Hg for aged <60 and 60-<70, and 135 mm Hg for aged 70-<80)

The relationship between on-treatment systolic blood pressure and primary outcome in very old hypertensive CAD patients follows a J-shaped curve, with the hazard ratio nadir at 140 mm Hg -- higher tha

Effect: mixed; HR nadir at SBP 140 mm Hg for very old (vs 110 mm Hg for aged <60 and 60-<70, and 135 mm Hg for aged 70-<80)

The relationship between on-treatment systolic blood pressure and primary outcome in very old hypertensive CAD patients follows a J-shaped curve, with the hazard ratio nadir at 140 mm Hg -- higher tha

Effect: mixed; HR nadir at SBP 140 mm Hg for very old (vs 110 mm Hg for aged <60 and 60-<70, and 135 mm Hg for aged 70-<80)

The relationship between on-treatment systolic blood pressure and primary outcome in very old hypertensive CAD patients follows a J-shaped curve, with the hazard ratio nadir at 140 mm Hg -- higher tha

Effect: mixed; HR nadir at SBP 140 mm Hg for very old (vs 110 mm Hg for aged <60 and 60-<70, and 135 mm Hg for aged 70-<80)

The relationship between on-treatment systolic blood pressure and primary outcome in very old hypertensive CAD patients follows a J-shaped curve, with the hazard ratio nadir at 140 mm Hg -- higher tha

Effect: mixed; HR nadir at SBP 140 mm Hg for very old (vs 110 mm Hg for aged <60 and 60-<70, and 135 mm Hg for aged 70-<80)

The relationship between on-treatment systolic blood pressure and primary outcome in very old hypertensive CAD patients follows a J-shaped curve, with the hazard ratio nadir at 140 mm Hg -- higher tha

Effect: mixed; HR nadir at SBP 140 mm Hg for very old (vs 110 mm Hg for aged <60 and 60-<70, and 135 mm Hg for aged 70-<80)

The relationship between on-treatment systolic blood pressure and primary outcome in very old hypertensive CAD patients follows a J-shaped curve, with the hazard ratio nadir at 140 mm Hg -- higher tha

Effect: mixed; HR nadir at SBP 140 mm Hg for very old (vs 110 mm Hg for aged <60 and 60-<70, and 135 mm Hg for aged 70-<80)